Tynan, M., Peshkin, B. N., Isaacs, C., Willey, S., Valdimarsdottir, H. B., Nusbaum, R., … Schwartz, M. D. (2020). Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients. Breast Cancer Research and Treatment, 180(1), 177–185. https://doi.org/10.1007/s10549-019-05515-2

Tynan, Mara, Beth N. Peshkin, Claudine Isaacs, Shawna Willey, Heiddis B. Valdimarsdottir, Rachel Nusbaum, Gillian Hooker, et al. “Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.” Breast Cancer Research and Treatment 180, no. 1 (February 2020): 177–85. https://doi.org/10.1007/s10549-019-05515-2.

Tynan M, Peshkin BN, Isaacs C, Willey S, Valdimarsdottir HB, Nusbaum R, et al. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients. Breast Cancer Research and Treatment. 2020 Feb;180(1):177–85.

Tynan, Mara, et al. “Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.” Breast Cancer Research and Treatment, vol. 180, no. 1, Springer Science and Business Media LLC, Feb. 2020, pp. 177–85. Crossref, doi:10.1007/s10549-019-05515-2.

Tynan M, Peshkin BN, Isaacs C, Willey S, Valdimarsdottir HB, Nusbaum R, Hooker G, O’Neill SC, Jandorf L, Kelly SP, Heinzmann J, Kelleher S, Poggi E, Schwartz MD. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020 Feb;180(1):177–185.